Clinical Trial Update: Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating a nitric oxide releasing mouthwash (NORM) for the management of oropharyngeal candidiasis (oral candidiasis).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Candidiasis

Drugs mentioned

• Nitric Oxide Releasing Mouthwash (NORM) (Nitric oxide releasing mouthwash)

Snippet

Sponsor: Sanotize Research and Development corp. | Conditions: Candidiasis, Oral | Phase 1 | Status: COMPLETED